Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Worldwide, Sebaceous Gland Carcinoma (SGC) constitutes 3.2% of all eyelid malignant tumors and 0.8% of all eyelid tumors. However, studies from India and China report a significantly higher incidence of SGC (28% of all eyelid malignancies). The reported mortality rate in SGC of eyelid is 22% [1]. SGC most commonly arises from the meibomian glands, occasionally from the glands of Zeis or Moll, and from sebaceous glands in caruncle.